Parathyroid glands and the multiple endocrine neoplasia syndromes and familial hypocalciuric hypercalcemia

Seminars in Surgical Oncology

Volumn 13, Issue 2, 1997, Pages 114-124

  Herfarth, Klaus K ^a   Wells Jr , Samuel A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

familial hypocalciuric hypercalcemia; hyperparathyroidism; multiple endocrine neoplasia; parathyroid glands; RET proto oncogenes

Indexed keywords

ARTICLE; CALCIUM HOMEOSTASIS; CHROMOSOME 11; CLINICAL FEATURE; DISEASE ASSOCIATION; GENE LOCATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; HYPERPARATHYROIDISM; MULTIPLE ENDOCRINE NEOPLASIA; PRIORITY JOURNAL; PROTO ONCOGENE;

HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; MULTIPLE ENDOCRINE NEOPLASIA; PARATHYROID GLANDS; PARATHYROIDECTOMY;

EID: 0031003661     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199703/04)13:2<114::AID-SSU7>3.0.CO;2-C     Document Type: Article

References (57)

1. Erdheim J: Zur normalen und pathologischen Histologie der glandula thyreoidea, parathyreoidea und hypophysis. Beitr path Anat allg Path 1903;33:158-236.
2. Wermer P: Genetic aspects of adenomatosis of endocrine glands. Am J Med 1954;16:363-371.
3. Steiner AL, Goodman AD, Powers SR: Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: multiple endocrine neoplasia, type 2. Medicine 1968;47:371-409.
4. Chong GC, Beahrs OH, Sizemore GW, Woolner LB: Medullary carcinoma of the thyroid gland. Cancer 1975;35:695-704.
5. Foley TP Jr, Harrison HC, Arnaud CD, Harrison HE: Familial benign hypercalcemia. J Pediatr 1972;82:1060-1067.
6. Marx SJ, Spiegel AM, Brown EM, Aurbach GD: Family studies in patients with primary hyperparathyroidism. Am J Med 1977;62:698-706.
7. Boey JH, Cooke TJ, Gilbert JM, et al: Occurrence of other endocrine tumours in primary hyperparathyroidism. Lancet 1975;2(7939):781-784.
8. Krementz ET, Yeager R, Hawley W, Weichert R: The first 100 cases of parathyroid tumor from Charity Hospital of Louisiana. Ann Surg 1971;173:872-883.
9. Christensson, T: Familial hyperparathyroidism. Ann Intern Med 1976;85:614-615
10. Hellman P, Skogseid B, Juhlin C, et al: Findings and long-term result of parathyroid surgery in multiple endocrine neoplasia type 1. World J Surg 1992;16:718-723.
11. Marx SJ, Vinik AI, Santen RJ, et al: Multiple endocrine neoplasia type I: assessment of laboratory tests to screen for the gene in a large kindred. Medicine 1986;65:226-241.
12. O'Riordain DS, O'Brien T, Grant CS, et al: Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia types 1 and 2. Surgery 1993;114:1031-1039.
13. Benson L, Ljunghall S, Åkerström G, Öberg K: Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1. Am J Med 1987;82:731-737.
14. Samaan NA, Quais S, Ordonez NG, et al: Multiple endocrine syndrome type 1. Clinical, laboratory findings and management in five families. Cancer 1989;64:741-752.
15. Prinz RA, Gamvros OI, Sellu D, Lynn DA: Subtotal parathyroidectomy in primary chief cell hyperplasia of the multiple endocrine neoplasia type 1 syndrome. Ann Surg 1981,193:26-29.
16. Skogseid B, Eriksson B, Lundqvist G, et al: Multiple endocrine neoplasia type 1: A 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab 1991;73:281-287.
17. Larsson C, Skogseid B, Öberg K, et al: Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988;332(6159):85-87.
18. Thakker RV, Bouloux P, Wooding C, et al: Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med 1989;321:218-224.
19. Knudson AG, Jr.: Mutation and cancer. Statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820-823.
20. Pang JT, Thakker RV: Multiple endocrine neoplasia type 1 (MEN 1) [review]. Eur J Cancer 1994;30A:1961-1968.
21. Pang JT, Lloyd SE, Wooding C, et al: Genetic mapping studies of 40 loci and 23 cosmids in chromosome 11p13-11q13, and exclusion of μ-calpain as the multiple endocrine neoplasia type 1 gene. Hum Genet 1996;97:732-741.
22. Larsson C, Calender A, Grimmond S, et al: Molecular tools for presymptomatic testing in multiple endocrine neoplasia type 1. J Intern Med 1995;238:239-244.
23. Brandi ML, Aurbach GD, Fitzpatrick LA, et al: Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1. N Eng J Med 1986;314:1297-1293.
24. rd, et al: Mitogenic activity on parathyroid cells in plasma from members of a large kindred with multiple endocrine neoplasia type 1. J Endocrinol Metab 1988;67:149-153.
25. Komatsu M, Tsuchiya S, Matsuyama I, et al: Expression of basic fibroblast growth factor in hyperplastic parathyroid glands from patients with multiple endocrine neoplasia type I. World J Surg 1994;18:921-924; discussion 925.
26. Kraimps JL, Duh QY, Demeure M, Clark OH: Hyperparathyroidism in multiple endocrine neoplasia syndrome. Surgery 1992; 112:1080-1088.
27. Lamers CB, Froeling PG: Clinical significance of hyperparathyroidism in familial multiple endocrine adenomatosis type 1 (MEA 1). Am J Med 1979;66:422-424.
28. Marx SJ, Menczel J, Campbell G, et al: Heterogeneous size of the parathyroid glands in familial multiple endocrine neoplasia type I. Clin Endocrinol 1991;35:521-526.
29. Grimelius L, Bondeson L: Histopathological diagnosis of parathyroid disease. [Review] Pathol Res Pract 1995;191:353-365.
30. Friedman E, De Marco L, Gejman PV, et al: Allelic loss from chromosome 11 in parathyroid tumors. Cancer Res 1992;52:6804-6809.
31. Mallette LE, Blevins T, Jordan PH, Noon GP: Autogenous parathyroid grafts for generalized primary hyperparathyroidism: contrasting outcome in sporadic hyperplasia versus multiple endocrine neoplasia type 1. Surgery 1987;101:738-745.
32. Wells SA Jr, Farndon JR, Dale JK, et al: Long-term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation. Ann Surg 1980;192:451-456.
33. Rizzoli R, Green H 3rd, Marx SJ: Primary hyperparathyroidism in familial multiple endocrine neoplasia type 1. Am J Med 1985; 78:468-473.
34. Thompson NW: The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient. J Intern Med 1995;238:269-280.
35. Norton JA, Cornelius MJ, Doppman JL, et al: Effect of parathyroidectomy in patients with hyperparathyroidism and multiple endocrine neoplasia type 1: A prospective study. Surgery 1987;102:958-966.
36. Howe JR, Norton JA, Wells SA, Jr.: Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: results of long-term follow-up. Surgery 1993;114:1070-1077.
37. Donis-Keller H, Dou S, Chi D, et al: Mutations in the RET protooncogene are associated with MEN 2A and FMTC. Hum Mol Genet 1993;2.851-856.
38. Mulligan LM, Kwok JB, Healey CS, et al: Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993;363(6428):458-460.
39. Santoro M, Carlomagno F, Romano A, et al: Activation of RET as a dominant transforming gene by germline mutations of MEN 2A and MEN 2B. Science 1995;267(5196):381-383.
40. Mulligan LM, Marsh DJ, Robinson BG, et al: Genotype-phenotype correlation in multiple endocrine neoplasia type 2. report of the International RET Mutation Consortium. J Intern Med 1995;238:343-346.
41. Mulligan LM, Eng C, Healey CS, et al: Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet 1994;6:70-74.
42. Herfarth KK, Bartsch D, Doherty GM, et al: Surgical management of hyperparathyroidism in patients with multiple endocrine neoplasia type 2A Surgery 1996;120:966-974.
43. Schuffenecker I, Billaud M, Calender A, et al: RET proto-oncogene mutations in French MEN 2A and FMTC families. Hum Mol Genet 1994,3:1939-1943.
44. Wells SA Jr, Chi DD, Toshima K, et al: Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg 1994;220:237-247.
45. Raue F, Kraimps JL, Dralle H, et al: Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. J Intern Med 1995; 238:369-373.
46. Olson JA, DeBenedetti MK, Baumann DS, Wells SA, Jr: Parathyroid autotransplantation during thyroidectomy. Results of long-term follow-up. Ann Surg 1996;223:472-480.
47. Carlson KM, Dou S, Chi D, et al: Single missense mutation of tyrosine kinase catalytic domain of the RET proto-oncogene is associated with multiple endocrine neoplasia type 2B. Proc Nat Acad Sci USA 1994;91:1579-1583.
48. Hofstra RM, Landsvater RM, Ceccherini I, et al: A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 1994; 367(6461):375-376
49. Carney JA, Roth SI, Heath H 3rd, et al: The parathyroid glands in multiple endocrine neoplasia type 2a. Am J Pathol 1980; 99:387-395.
50. Pollak MR, Brown EM, Chou YH, et al: Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993; 75:1297-1303.
51. Heath H 3rd, Odelberg S, Jackson CE, et al: Clustered inactivation mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains. J Clin Endocrinol Metab 1996;81:1312-1317.
52. Pollak MR, Chou YH, Marx SJ, et al: Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest 1994; 93:1108-1112.
53. Auwerx J, Brunzell J, Bouillon R, Demedts M: Familial hypocalciuric hypercalcemia - familial benign hypercalcemia: a review. Postgrad Med J 1987;63:835-840
54. Stuckey BG, Gutteridge DH, Kent GN, Reed WD: Familial hypocalciuric hypercalcemia and pancreatitis: no causal link proven. Aust NZ J Med 1990;20:718-725.
55. Heath DA: Familial hypocalciuric hypercalcemia. In Bilezikean JP, Levine MA, Marcus R (eds): "The Parathyroids." New York: Raven Press, 1994:699-710.
56. Law WM Jr, Carney JA, Heath H 3rd: Parathyroid glands in familial benign hypercalcemia (familial hypocalciuric hypercalcemia). Am J Med 1984;76:1021-1026
57. Harris SS, D'Ercole AJ: Neonatal hyperparathyroidism: the natural course in absence of surgical intervention. Pediatrics 1989; 83:53-56.